Protein misfolding and aggregation underlie major neurodegenerative diseases such as Alzheimers (AD), Parkinsons, and Huntingtons disease, further characterised by neuronal loss, mitochondrial dysfunction, toxic fibril formation, and oxidative stress
Older individuals may have different pharmacokinetics, meaning the peptide might be processed differently by the body
The serum, marketed as Syntha-Pep, arrives in a 5-milliliter ampoule that connects directly to the needle head in a sealed architecture: the serum never touches open air, fingertips, or an intermediate chamber between manufacturing and skin
doi: 10.1038/s41598-020-62157-x 90 Ruiz-PablosMPaivaBMontero-MateoRGarciaNZabaletaA
competes with FOXO4 for p53 in senescent cells